Matthew H. Taylor, MD
Earle A. Chiles Research Institute - Providence Cancer Institute
Medical director, Providence Cancer Institute Thyroid Cancer Program
Co-medical director, Providence Cancer Institute Melanoma Program
Dr. Taylor is board-certified in medical oncology and internal medicine. As a physician scientist, he divides his time between his Providence clinical practice in the Franz Clinic at the Robert W. Franz Cancer Center and his research laboratory in the Earle A. Chiles Research Institute, a Providence Center of Excellence for immuno-oncology and cellular therapy.
His clinical specialties include treating patients with melanoma and advanced thyroid cancer, and conducting early phase clinical trials. Dr. Taylor is an experienced clinical investigator. He has served as principal investigator on many clinical trials that have resulted in approval of new treatment options for patients with advanced cancer.
The Developmental Cancer Therapeutics Lab studies novel approaches to help patients’ immune systems fight their cancers.
- Fellowship in oncology/hematology, Oregon Health & Science University, 2007-2010
- Residency in internal medicine, University of Washington, 2005-2007
- Doctor of Medicine, Oregon Health & Science University, 2005
- Bachelor of Science in microbiology/chemistry, Brigham Young University, 2001
- Medical director, Providence Thyroid Cancer Program, Providence Cancer Institute, 2021-present
- Assistant member, Earle A. Chiles Research Institute, Providence Cancer Institute, 2019-present
- Co-medical director, Providence Melanoma Program, Providence Cancer Institute, 2019-present
- Associate professor, Division of Hematology & Oncology, Oregon Health & Science University, 2019
- Assistant professor, Division of Hematology & Oncology, Oregon Health & Science University, 2010-2019
- Chief fellow, Division of Hematology & Oncology, Oregon Health & Science University, 2009-2010
- American Association of Cancer Research
- American Society of Clinical Oncology
- International Thyroid Oncology Group
- Society for Immunotherapy of Cancer
- Southwest Oncology Group
- Cum Laude, Oregon Health & Science University Medical School; 2003-2005
- Elizabeth A. Koch Research Award, Finch University of Health Science/The Chicago Medical School, 2002-2003
- Morris A. Kaplan Research Award, American Academy of Allergy Asthma & Immunology Research Fellowship, 2001-2002
- Cancer Research Award, Member of the Blue Key National Honor Society, Brigham Young University, 2000-2001
Dr. Taylor’s research is published in peer-reviewed scientific and medical journals. He has partnered with colleagues on various research projects.